GENFIT (EPA:GNFT) | Finanzwire

BRIEF

published on 09/28/2026 at 19:56, 19 days 9 hours ago

GENFIT Announces H1 2026 Financial Performance and Strategic Developments

R&D Pipeline GENFIT Financials Biopharmaceutical Developments MASH Diagnostics Ipsen Agreement
PRESS RELEASE

published on 09/28/2026 at 19:51, 19 days 10 hours ago

GENFIT Reports First-Half 2026 Financial Results and Provides Corporate Update
GENFIT reports first-half 2026 financial results and provides corporate update including significant revenue growth, strategic developments and future milestones

Revenues Financial Results Corporate Update Milestones GENFIT
BRIEF

published on 09/14/2026 at 18:20, 1 month 3 days ago

GENFIT Initiates Phase 2 Trials for Nangibotide in ACLF

Phase 2 Trials Liver Diseases GENFIT ACLF Nangibotide
PRESS RELEASE

published on 09/14/2026 at 18:15, 1 month 3 days ago

GENFIT Advances Nangibotide in Phase 2 Clinical Investigation in ACLF
GENFIT strengthens pipeline with acquisition of nangibotide for ACLF treatment in Phase 2 trial. Positive efficacy and safety signals observed. Details at The Liver Meeting in Denver, November 2026

Phase 2 Trial GENFIT ACLF Nangibotide The Liver Meeting
BRIEF

published on 09/11/2026 at 07:35, 1 month 6 days ago

GENFIT Joins CAC Mid 60 and SBF 120 Indices

Institutional Investors Market Capitalization SBF 120 CAC Mid 60 GENFIT Inclusion
BRIEF

published on 09/11/2026 at 07:35, 1 month 6 days ago

GENFIT is included in the CAC Mid 60 and SBF 120 indices

Biopharmaceutical SBF 120 GENFIT CAC Mid 60 Stock Market Indices
PRESS RELEASE

published on 09/11/2026 at 07:30, 1 month 6 days ago

GENFIT to Join CAC Mid 60 and SBF 120 Indices on Euronext Paris
GENFIT to join CAC Mid 60 and SBF 120 indices on Euronext Paris after annual review, enhancing visibility and market profile. CEO Pascal Prigent confirms company's commitment to innovative therapies and long-term value creation

Euronext Paris Biopharmaceutical SBF 120 GENFIT CAC Mid 60
BRIEF

published on 09/09/2026 at 07:35, 1 month 8 days ago

GENFIT Explores Long-Term Prospects for MASH Diagnostic Technology

U.S. Market GENFIT Commercial Opportunity MASH Diagnostics NISTM Technology
PRESS RELEASE

published on 09/09/2026 at 07:30, 1 month 8 days ago

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
GENFIT highlights long-term commercial opportunity for its MASH Diagnostics Technology. The technology aims to identify patients with 'at-risk MASH' through non-invasive blood-based testing, creating potential for significant revenue streams

GENFIT Commercial Opportunity MASH Diagnostics NISTM Technology Patient Identification
BRIEF

published on 05/11/2026 at 19:05, 5 months 6 days ago

GENFIT's Annual Meeting: Preparatory Documents Available

Shareholders Annual Meeting Liver Diseases GENFIT Online Voting

1 2 ... 8

Published on 10/17/2026 at 03:20, 1 day 2 hours ago

Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 1 day 2 hours ago

Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 1 day 6 hours ago

Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 1 day 6 hours ago

NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 1 day 6 hours ago

Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update

View all ACCESSWIRE

Published on 10/17/2026 at 18:00, 11 hours 52 minutes ago

Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 16 hours 47 minutes ago

Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 17 hours 2 minutes ago

AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 1 day 9 hours ago

EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 1 day 10 hours ago

Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation

View all EQS

Published on 10/16/2026 at 18:48, 1 day 11 hours ago

Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 07:30, 1 day 22 hours ago

Third Quarter Revenues 2026
Published on 10/15/2026 at 18:50, 2 days 11 hours ago

September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 2 days 12 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 10/15/2026 at 17:45, 2 days 12 hours ago

VOGO : H1 2026 results.

View all LES ECHOS COMFI WIRE

News